Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Teva
Queensland Health
Chinese Patent Office
Argus Health
Covington
Boehringer Ingelheim
Colorcon
Fish and Richardson
Accenture

Generated: October 21, 2017

DrugPatentWatch Database Preview

IMPAVIDO Drug Profile

« Back to Dashboard

Which patents cover Impavido, and what generic Impavido alternatives are available?

Impavido is a drug marketed by Knight Theraps and is included in one NDA.

The generic ingredient in IMPAVIDO is miltefosine. Two suppliers are listed for this compound. Additional details are available on the miltefosine profile page.

Summary for Tradename: IMPAVIDO

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list55
Clinical Trials: see list9
Patent Applications: see list3,099
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMPAVIDO at DailyMed

Pharmacology for Tradename: IMPAVIDO

Drug ClassAntileishmanial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Knight Theraps
IMPAVIDO
miltefosine
CAPSULE;ORAL204684-001Mar 19, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Knight Theraps
IMPAVIDO
miltefosine
CAPSULE;ORAL204684-001Mar 19, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Julphar
Federal Trade Commission
Mallinckrodt
Daiichi Sankyo
AstraZeneca
Teva
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot